Influence of Shenlian decoction on early lesion of atherosclerosis in rats / 中国中药杂志
China Journal of Chinese Materia Medica
; (24): 66-71, 2011.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-289427
Biblioteca responsável:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To establish the atherosclerosis models (AS) in rats and observe the change process of AS and Shenlian decoction's pharmacological effect.</p><p><b>METHOD</b>Two hundreds and forty rats were randomly divided into blank control group, model group, positive medicine group, the high-dose, middle dose and low-dose Shenlian decoction groups. Vascular pathological changes were observed by the methods of HE stain. The levels of TC, TG, LDL-C, HDL-C, NO in serum were determined respectively by enzyme colorimetric, clear and nitrate reductase methods. ET, TXB2, 6-keto-PGF1 alpha, TNF-alpha, IL-6 and IL-8 levels in serum were detected by radioimminoassay.</p><p><b>RESULT</b>Compared with the model group, vascular lesion of different doses of Shenlian decoction groups were significantly improved, the TG, NO, TXB2 levels in serum were significantly lower (P < 0.05), while high-dose Shenlian decoction can significantly reduce TNF-alpha, IL-6, IL-8 levels in serum (P < 0.05).</p><p><b>CONCLUSION</b>Shenlian decoction can inhibit the formation and development of AS by regulating blood lipids, improving endothelial function and reducing inflammatory factors release.</p>
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Assunto principal:
Patologia
/
Sangue
/
Medicamentos de Ervas Chinesas
/
Distribuição Aleatória
/
Interleucina-6
/
Fator de Necrose Tumoral alfa
/
Ratos Wistar
/
Substâncias Protetoras
/
Modelos Animais de Doenças
/
Tratamento Farmacológico
Tipo de estudo:
Ensaio clínico controlado
/
Estudo prognóstico
Limite:
Animais
/
Humanos
/
Masculino
Idioma:
Chinês
Revista:
China Journal of Chinese Materia Medica
Ano de publicação:
2011
Tipo de documento:
Artigo